The current situation of transcatheter aortic valve replacement in China 2017_West China Medical Journal

Authors：

PAN Wenzhi , ZHOU Daxin ,  GE Junbo

Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, P. R. China;

Corresponding?author：

GE Junbo, Email: ge.junbo2@zs-hospital.sh.cn

Keywords：

Transcatheter aortic valve replacement; Aortic stenosis; Domestic prostheses

DOI：

10.7507/1002-0179.201711135

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Transcatheter aortic valve replacement (TAVR) as a mature technology has been widely applied in Western countries. In China, with the first two domestic prostheses being approved for commercial use, the technology now is expecting a fast development. In this article, we reviewed the features of Chinese aortic stenosis patients, the early Chinese experience of TAVR, the application of domestic prostheses and remaining problems.

Citation： PAN Wenzhi, ZHOU Daxin, GE Junbo. The current situation of transcatheter aortic valve replacement in China 2017. West China Medical Journal, 2018, 33(2): 132-136. doi: 10.7507/1002-0179.201711135 Copy

1.	Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart disease: a report of the American College of Cardiology/American Heart Association Task Force On Clinical Practice Guidelines. J Am Coll Cardiol, 2017, 70(2): 252-289.
2.	Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American college of cardiology/American heart association task force on practice guidelines. Circulation, 2014, 129(23): E521-E643.
3.	Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J, 2017, 38(36): 2739-2791.
4.	Thourani VH, Kodali S, Makkar RR, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity socre analysis. Lancet, 2016, 387(10034): 2218-2225.
5.	顧明標, 白元, 宗剛軍, 等. 帶瓣膜主動脈瓣支架的研制及體外經導管植入實驗. 第二軍醫大學學報, 2009, 30(2): 117-119.
6.	宋艷斌, 蔡菁, 孫偉, 等. 經導管人工生物主動脈瓣膜置換動物實驗. 南京醫科大學學報: 自然科學版, 2011, 31(8): 1097-1100, 1147.
7.	葛均波, 周達新, 潘文志, 等. 經皮主動脈瓣植入術一例及其操作要點. 中國介入心臟病學雜志, 2010, 18(5): 243-246.
8.	雍偉哲. 國家心血管病中心首次成功經導管置入國產主動脈瓣裝置——我國國產經導管置入主動脈瓣裝置臨床試驗正式啟動. 中華醫學信息導報, 2012, 27(19): 5.
9.	Jilaihawi H, Wu Y, Yang Y, et al. Morphological characteristics of severe aortic stenosis in China: imaging corelab observations from the first Chinese transcatheter aortic valve trial. Catheter Cardiovasc Interv, 2015, 85(Suppl 1): 752-761.
10.	Pan W, Zhou D, Cheng L, et al. Aortic regurgitation is more prevalent than aortic stenosis in Chinese elderly population: implications for transcatheter aortic valve replacement. Int J Cardiol, 2015, 201: 547-548.
11.	白一帆. 成人心臟瓣膜病外科治療20年回顧及危險因素變遷. 上海: 第二軍醫大學, 2012.
12.	曹翔. 成人主動脈瓣置換術后在院死亡危險因素分析. 上海: 第二軍醫大學, 2012.
13.	潘文志, 周達新, 張蕾, 等. 經頸動脈途徑行經導管主動脈瓣置入術一例. 中華心血管病雜志, 2016, 44(4): 348-349.
14.	Liu XB, Jiang JB, Zhou Qj, et al. Evaluation of the safety and efficacy of transcatheter aortic valve implantation in patients with a severe stenoticbicuspid aortic valve in a Chinese population. J Zhejiang Univ Sci B, 2015, 16(3): 208-214.
15.	Xiong TY, Zheng MX, Wei X, et al. Hemodynamic changes after transcatheter aortic valve implantation during sequential follow-ups in patients with bicuspid aortic valve compared with tricuspid aortic valve. Cardiol J, 2017, 24(4): 350-357.
16.	中國醫師協會心血管內科醫師分會結構性心臟病專業委員會, 中華醫學會心血管病學分會結構性心臟病學組. 經導管主動脈瓣置換術中國專家共識. 中國介入心臟病學雜志, 2015, 23(12): 661-667.
17.	Jilaihawi H, Chen M, Webb J, et al. A bicuspid aortic valve imaging classification for the TAVR era. JACC Cardiovasc Imaging, 2016, 9(10): 1145-1158.
18.	Wei L, Liu H, Zhu L, et al. A new transcatheter aortic valve replacement system for predominant aortic regurgitation implantation of the J-Valve and early outcome. JACC Cardiovasc Interv, 2015, 8(14): 1831-1841.
19.	劉慶榮, 呂守良, 吳永健. 國產Venus A-Valve人工主動脈瓣膜的設計特點. 中國醫刊, 2015, 50(1): 9-10.
20.	Pan W, Zhou D, Cheng L, et al. Candidates for transcatheter aortic valve implantation may be fewer in China. Int J Cardiol, 2013, 168(5): e133-e134.
21.	潘文志, 周達新, 葛均波. 經導管主動脈瓣置換術在外科手術中、低危患者中的研究現狀及展望. 中國介入心臟病學雜志, 2016, 2(24): 107-109.

1. Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart disease: a report of the American College of Cardiology/American Heart Association Task Force On Clinical Practice Guidelines. J Am Coll Cardiol, 2017, 70(2): 252-289.
2. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American college of cardiology/American heart association task force on practice guidelines. Circulation, 2014, 129(23): E521-E643.
3. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J, 2017, 38(36): 2739-2791.
4. Thourani VH, Kodali S, Makkar RR, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity socre analysis. Lancet, 2016, 387(10034): 2218-2225.
5. 顧明標, 白元, 宗剛軍, 等. 帶瓣膜主動脈瓣支架的研制及體外經導管植入實驗. 第二軍醫大學學報, 2009, 30(2): 117-119.
6. 宋艷斌, 蔡菁, 孫偉, 等. 經導管人工生物主動脈瓣膜置換動物實驗. 南京醫科大學學報: 自然科學版, 2011, 31(8): 1097-1100, 1147.
7. 葛均波, 周達新, 潘文志, 等. 經皮主動脈瓣植入術一例及其操作要點. 中國介入心臟病學雜志, 2010, 18(5): 243-246.
8. 雍偉哲. 國家心血管病中心首次成功經導管置入國產主動脈瓣裝置——我國國產經導管置入主動脈瓣裝置臨床試驗正式啟動. 中華醫學信息導報, 2012, 27(19): 5.
9. Jilaihawi H, Wu Y, Yang Y, et al. Morphological characteristics of severe aortic stenosis in China: imaging corelab observations from the first Chinese transcatheter aortic valve trial. Catheter Cardiovasc Interv, 2015, 85(Suppl 1): 752-761.
10. Pan W, Zhou D, Cheng L, et al. Aortic regurgitation is more prevalent than aortic stenosis in Chinese elderly population: implications for transcatheter aortic valve replacement. Int J Cardiol, 2015, 201: 547-548.
11. 白一帆. 成人心臟瓣膜病外科治療20年回顧及危險因素變遷. 上海: 第二軍醫大學, 2012.
12. 曹翔. 成人主動脈瓣置換術后在院死亡危險因素分析. 上海: 第二軍醫大學, 2012.
13. 潘文志, 周達新, 張蕾, 等. 經頸動脈途徑行經導管主動脈瓣置入術一例. 中華心血管病雜志, 2016, 44(4): 348-349.
14. Liu XB, Jiang JB, Zhou Qj, et al. Evaluation of the safety and efficacy of transcatheter aortic valve implantation in patients with a severe stenoticbicuspid aortic valve in a Chinese population. J Zhejiang Univ Sci B, 2015, 16(3): 208-214.
15. Xiong TY, Zheng MX, Wei X, et al. Hemodynamic changes after transcatheter aortic valve implantation during sequential follow-ups in patients with bicuspid aortic valve compared with tricuspid aortic valve. Cardiol J, 2017, 24(4): 350-357.
16. 中國醫師協會心血管內科醫師分會結構性心臟病專業委員會, 中華醫學會心血管病學分會結構性心臟病學組. 經導管主動脈瓣置換術中國專家共識. 中國介入心臟病學雜志, 2015, 23(12): 661-667.
17. Jilaihawi H, Chen M, Webb J, et al. A bicuspid aortic valve imaging classification for the TAVR era. JACC Cardiovasc Imaging, 2016, 9(10): 1145-1158.
18. Wei L, Liu H, Zhu L, et al. A new transcatheter aortic valve replacement system for predominant aortic regurgitation implantation of the J-Valve and early outcome. JACC Cardiovasc Interv, 2015, 8(14): 1831-1841.
19. 劉慶榮, 呂守良, 吳永健. 國產Venus A-Valve人工主動脈瓣膜的設計特點. 中國醫刊, 2015, 50(1): 9-10.
20. Pan W, Zhou D, Cheng L, et al. Candidates for transcatheter aortic valve implantation may be fewer in China. Int J Cardiol, 2013, 168(5): e133-e134.
21. 潘文志, 周達新, 葛均波. 經導管主動脈瓣置換術在外科手術中、低危患者中的研究現狀及展望. 中國介入心臟病學雜志, 2016, 2(24): 107-109.

Previous Article
Current status of valvular heart disease in China
Next Article
Heart team construction and operation in transcatheter aortic valve replacement

West China Medical Journal

The current situation of transcatheter aortic valve replacement in China 2017

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content